This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hung, M.
Right arrow Articles by Green, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hung, M.
Right arrow Articles by Green, S. R.

 Previous Article  |  Next Article 

J Virol, June 1998, p. 4819-4824, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Importance of Ribosomal Frameshifting for Human Immunodeficiency Virus Type 1 Particle Assembly and Replication

Magdeleine Hung, Pratiksha Patel, Susan Davis, and Simon R. Green*

RiboGene Inc., Hayward, California 94545

Received 31 October 1997/Accepted 17 February 1998

The recent development and use of protease inhibitors have demonstrated the essential role that combination therapy will play in the treatment of individuals infected with the human immunodeficiency virus type 1 (HIV-1). Past clinical experience suggests that due to the appearance of resistant HIV-1 variants, additional therapeutics will be required in the future. To identify new options for combination therapy, it is of paramount importance to pursue novel targets for drug development. Ribosomal frameshifting is one potential target that has not been fully explored. Data presented here demonstrate that small molecules can stimulate frameshifting, leading to an imbalance in the ratio of Gag to Gag-Pol and inhibiting HIV-1 replication at what appears to be the point of viral particle assembly. Thus, we propose that frameshifting represents a new target for the identification of novel anti-HIV-1 therapeutics.


* Corresponding author. Mailing address: RiboGene Inc., 26118 Research Rd., Hayward, CA 94545. Phone: (510) 732-5551. Fax: (510) 732-7741. E-mail: sgreen{at}ribogene.com.


J Virol, June 1998, p. 4819-4824, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Prado, J. G., Honeyborne, I., Brierley, I., Puertas, M. C., Martinez-Picado, J., Goulder, P. J. R. (2009). Functional Consequences of Human Immunodeficiency Virus Escape from an HLA-B*13-Restricted CD8+ T-Cell Epitope in p1 Gag Protein. J. Virol. 83: 1018-1025 [Abstract] [Full Text]  
  • Dulude, D., Theberge-Julien, G., Brakier-Gingras, L., Heveker, N. (2008). Selection of peptides interfering with a ribosomal frameshift in the human immunodeficiency virus type 1. RNA 14: 981-991 [Abstract] [Full Text]  
  • Gendron, K., Charbonneau, J., Dulude, D., Heveker, N., Ferbeyre, G., Brakier-Gingras, L. (2008). The presence of the TAR RNA structure alters the programmed -1 ribosomal frameshift efficiency of the human immunodeficiency virus type 1 (HIV-1) by modifying the rate of translation initiation. Nucleic Acids Res 36: 30-40 [Abstract] [Full Text]  
  • Waas, W. F., Druzina, Z., Hanan, M., Schimmel, P. (2007). Role of a tRNA Base Modification and Its Precursors in Frameshifting in Eukaryotes. J. Biol. Chem. 282: 26026-26034 [Abstract] [Full Text]  
  • Zook, M. B., Howard, M. T., Sinnathamby, G., Atkins, J. F., Eisenlohr, L. C. (2006). Epitopes Derived by Incidental Translational Frameshifting Give Rise to a Protective CTL Response.. J. Immunol. 176: 6928-6934 [Abstract] [Full Text]  
  • Muldoon-Jacobs, K. L., Dinman, J. D. (2006). Specific effects of ribosome-tethered molecular chaperones on programmed -1 ribosomal frameshifting.. Eukaryot Cell 5: 762-770 [Abstract] [Full Text]  
  • Wills, N. M., Moore, B., Hammer, A., Gesteland, R. F., Atkins, J. F. (2006). A Functional -1 Ribosomal Frameshift Signal in the Human Paraneoplastic Ma3 Gene. J. Biol. Chem. 281: 7082-7088 [Abstract] [Full Text]  
  • Ennifar, E., Paillart, J.-C., Bodlenner, A., Walter, P., Weibel, J.-M., Aubertin, A.-M., Pale, P., Dumas, P., Marquet, R. (2006). Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: from crystal to cell.. Nucleic Acids Res 34: 2328-2339 [Abstract] [Full Text]  
  • Cornish, P. V., Hennig, M., Giedroc, D. P. (2005). A loop 2 cytidine-stem 1 minor groove interaction as a positive determinant for pseudoknot-stimulated -1 ribosomal frameshifting. Proc. Natl. Acad. Sci. USA 102: 12694-12699 [Abstract] [Full Text]  
  • Makelainen, K., Makinen, K. (2005). Factors affecting translation at the programmed -1 ribosomal frameshifting site of Cocksfoot mottle virus RNA in vivo. Nucleic Acids Res 33: 2239-2247 [Abstract] [Full Text]  
  • BARIL, M., DULUDE, D., GENDRON, K., LEMAY, G., BRAKIER-GINGRAS, L. (2003). Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M. RNA 9: 1246-1253 [Abstract] [Full Text]  
  • Chen, C., Montelaro, R. C. (2003). Characterization of RNA Elements That Regulate Gag-Pol Ribosomal Frameshifting in Equine Infectious Anemia Virus. J. Virol. 77: 10280-10287 [Abstract] [Full Text]  
  • Staple, D. W., Butcher, S. E. (2003). Solution structure of the HIV-1 frameshift inducing stem-loop RNA. Nucleic Acids Res 31: 4326-4331 [Abstract] [Full Text]  
  • Brunelle, M.-N., Brakier-Gingras, L., Lemay, G. (2003). Replacement of Murine Leukemia Virus Readthrough Mechanism by Human Immunodeficiency Virus Frameshift Allows Synthesis of Viral Proteins and Virus Replication. J. Virol. 77: 3345-3350 [Abstract] [Full Text]  
  • Hill, M. K., Shehu-Xhilaga, M., Crowe, S. M., Mak, J. (2002). Proline Residues within Spacer Peptide p1 Are Important for Human Immunodeficiency Virus Type 1 Infectivity, Protein Processing, and Genomic RNA Dimer Stability. J. Virol. 76: 11245-11253 [Abstract] [Full Text]  
  • Telenti, A., Martinez, R., Munoz, M., Bleiber, G., Greub, G., Sanglard, D., Peters, S. (2002). Analysis of Natural Variants of the Human Immunodeficiency Virus Type 1 gag-pol Frameshift Stem-Loop Structure. J. Virol. 76: 7868-7873 [Abstract] [Full Text]  
  • Dinman, J. D., Richter, S., Plant, E. P., Taylor, R. C., Hammell, A. B., Rana, T. M. (2002). The frameshift signal of HIV-1 involves a potential intramolecular triplex RNA structure. Proc. Natl. Acad. Sci. USA 99: 5331-5336 [Abstract] [Full Text]  
  • Shehu-Xhilaga, M., Hill, M., Marshall, J. A., Kappes, J., Crowe, S. M., Mak, J. (2002). The Conformation of the Mature Dimeric Human Immunodeficiency Virus Type 1 RNA Genome Requires Packaging of Pol Protein. J. Virol. 76: 4331-4340 [Abstract] [Full Text]  
  • Huang, Y., Kong, W.-p., Nabel, G. J. (2001). Human Immunodeficiency Virus Type 1-Specific Immunity after Genetic Immunization Is Enhanced by Modification of Gag and Pol Expression. J. Virol. 75: 4947-4951 [Abstract] [Full Text]  
  • BRIERLEY, I., PENNELL, S. (2001). Structure and Function of the Stimulatory RNAs Involved in Programmed Eukaryotic -1 Ribosomal Frameshifting. Cold Spring Harb Symp Quant Biol 66: 233-248 [Abstract]  
  • Wilson, G. M., Brewer, G. (1999). Slip-Sliding the Frame: Programmed -1 Frameshifting on Eukaryotic Transcripts. Genome Res 9: 393-394 [Full Text]